Date Filed | Type | Description |
05/19/2023 |
4
| PARMAR KUSH (Director) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 15,490 options to buy
@ $5.64, valued at
$87.4k
|
|
05/19/2023 |
4
| Nash Christine A (Director) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 15,490 options to buy
@ $5.64, valued at
$87.4k
|
|
05/19/2023 |
4
| Boudreau Helen M (Director) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 15,490 options to buy
@ $5.64, valued at
$87.4k
|
|
05/19/2023 |
4
| Hopfner Robert Lorne (Director) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 15,490 options to buy
@ $5.64, valued at
$87.4k
|
|
05/19/2023 |
4
| Soteropoulos Paula (Director) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 15,490 options to buy
@ $5.64, valued at
$87.4k
|
|
05/19/2023 |
4
| Liu Hui (Director) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 15,490 options to buy
@ $5.64, valued at
$87.4k
|
|
05/19/2023 |
4
| HUNT RONALD (Director) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 15,490 options to buy
@ $5.64, valued at
$87.4k
|
|
05/19/2023 |
4
| Chung Wendy (Director) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 12,353 options to buy
@ $5.64, valued at
$69.7k
|
|
03/16/2023 |
4
| Lieber Jonathan I (See Remarks) has filed a Form 4 on Rallybio Corp
Txns:
| Bought 5,000 shares
@ $5.21, valued at
$26.1k
|
|
03/09/2023 |
4
| PARMAR KUSH (Director) has filed a Form 4 on Rallybio Corp
Txns:
| Sold 100,000 shares
@ $8.2, valued at
$820k
|
|
03/09/2023 |
4
| 5AM Partners V, LLC (10% Owner) has filed a Form 4 on Rallybio Corp
Txns:
| Sold 100,000 shares
@ $8.2, valued at
$820k
|
|
02/06/2023 |
4
| Uden Stephen (See Remarks) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 214,000 options to buy
@ $6.5, valued at
$1.4M
|
|
02/06/2023 |
4
| Ryder Steven (Chief Medical Officer) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 119,000 options to buy
@ $6.5, valued at
$773.5k
|
|
02/06/2023 |
4
| MACKAY MARTIN (CEO) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 214,000 options to buy
@ $6.5, valued at
$1.4M
|
|
02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/01/2023 |
3
| Lieber Jonathan I (See Remarks) has filed a Form 3 on Rallybio Corp |
01/05/2023 |
4
| Liu Hui (Director) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 10,237 options to buy
@ $6.19, valued at
$63.4k
|
|
01/05/2023 |
4
| PARMAR KUSH (Director) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 10,344 options to buy
@ $6.19, valued at
$64k
|
|
01/05/2023 |
4
| Chung Wendy (Director) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 9,482 options to buy
@ $6.19, valued at
$58.7k
|
|
01/05/2023 |
4
| HUNT RONALD (Director) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 11,099 options to buy
@ $6.19, valued at
$68.7k
|
|
11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/03/2022 |
4
| Chung Wendy (Director) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 26,880 options to buy
@ $9.11, valued at
$244.9k
|
|
08/03/2022 |
3
| Chung Wendy (Director) has filed a Form 3 on Rallybio Corp |
06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2022 |
4
| Liu Hui (Director) has filed a Form 4 on Rallybio Corp
Txns:
| Granted 2,240 options to buy
@ $12.75, valued at
$28.6k
|
|
05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|